Literature DB >> 9661038

Inhibitory effect of erythromycin on superoxide anion production by human neutrophils primed with granulocyte-colony stimulating factor.

J Kadota, T Iwashita, Y Matsubara, Y Ishimatsu, M Yoshinaga, K Abe, S Kohno.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9661038      PMCID： PMC105700     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  12 in total

1.  Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis.

Authors:  A M Cantin; S L North; G A Fells; R C Hubbard; R G Crystal
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

2.  Purification and cytotoxic potential of myeloperoxidase in cystic fibrosis sputum.

Authors:  J R Mohammed; B S Mohammed; L J Pawluk; D M Bucci; N R Baker; W B Davis
Journal:  J Lab Clin Med       Date:  1988-12

3.  Erythromycin reduces neutrophils and neutrophil-derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients.

Authors:  Y Ichikawa; H Ninomiya; H Koga; M Tanaka; M Kinoshita; N Tokunaga; T Yano; K Oizumi
Journal:  Am Rev Respir Dis       Date:  1992-07

4.  Erythromycin does not directly affect neutrophil functions.

Authors:  M Hojo; I Fujita; Y Hamasaki; M Miyazaki; S Miyazaki
Journal:  Chest       Date:  1994-02       Impact factor: 9.410

5.  Interleukin 1 beta, tumor necrosis factor alpha, and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: a potential mechanism of macrolide therapy.

Authors:  O Sakito; J Kadota; S Kohno; K Abe; R Shirai; K Hara
Journal:  Respiration       Date:  1996       Impact factor: 3.580

6.  Role of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway diseases.

Authors:  K Oishi; F Sonoda; S Kobayashi; A Iwagaki; T Nagatake; K Matsushima; K Matsumoto
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

7.  Leukotriene B4 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis.

Authors:  H Oda; J Kadota; S Kohno; K Hara
Journal:  Chest       Date:  1995-07       Impact factor: 9.410

8.  Inhibition by erythromycin of superoxide anion production by human polymorphonuclear leukocytes through the action of cyclic AMP-dependent protein kinase.

Authors:  T Mitsuyama; T Tanaka; K Hidaka; M Abe; N Hara
Journal:  Respiration       Date:  1995       Impact factor: 3.580

9.  Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme immunoassay reader.

Authors:  E Pick; D Mizel
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

10.  Long-term low-dose administration of erythromycin to patients with diffuse panbronchiolitis.

Authors:  H Nagai; H Shishido; R Yoneda; E Yamaguchi; A Tamura; A Kurashima
Journal:  Respiration       Date:  1991       Impact factor: 3.580
View more
  4 in total

Review 1.  Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"?

Authors:  M T Labro
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

Review 2.  Immuno-modulation and anti-inflammatory benefits of antibiotics: the example of tilmicosin.

Authors:  André G Buret
Journal:  Can J Vet Res       Date:  2010-01       Impact factor: 1.310

3.  Effect of proinflammatory cytokines on the interplay between roxithromycin, HMR 3647, or HMR 3004 and human polymorphonuclear neutrophils.

Authors:  D Vazifeh; A Bryskier; M T Labro
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

Review 4.  Anti-inflammatory and Immunomodulatory Effects of Antibiotics and Their Use in Dermatology.

Authors:  Swetalina Pradhan; Bhushan Madke; Poonam Kabra; Adarsh Lata Singh
Journal:  Indian J Dermatol       Date:  2016 Sep-Oct       Impact factor: 1.494
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.